🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

1/5 Great to see a the first published analysis of the NHS Galleri Trial at the ESMO conference last week in Madrid and the role of NHS DigiTrials in recruiting across a range of ages, socioeconomic and ethnic groups. Success in some areas yet more to do in others.

In July, we thanked 20,000 participants from Greater Manchester for joining the NHS Galleri Trial – the world’s largest research trial of a multi-cancer early detection blood test. Read more: bit.ly/4iGOZQI #GMNHSGalleri #GMCancerHighlights24

Running a randomised controlled cancer screening trial to evaluate a blood-based screening test? Peter Sasieni and evaluate sample size requirements for two innovative designs where the control arm are retrospectively tested. Wolfson Institute of Population Health oxford.ly/4iUun6D

A single blood test for the chemical signals of many different types of #cancer could detect the disease at its early stages, making it easier to treat for almost 50% of patients. The new study, led by Professor Peter Sasieni from Wolfson Institute of Population Health, reports today in BMJ_Open

In the latest conversation on the Healthy Longevity podcast, Eric Klein, MD and I explore how multi-cancer early detection (MCED) tests like Galleri are being rigorously studied across large-scale clinical trials. GRAIL, the company behind Galleri, is currently involved in 9

Delighted to share a link to my paper on "Promises and pitfalls of multi-cancer early detection using liquid biopsy tests" published in Nature Reviews Clinical Oncology NatureRevClinOncol with Jonathan C M Wan and Nitzan Rosenfeld #MCED Wolfson Institute of Population Health Barts Cancer Institute (Queen Mary) rdcu.be/eqRQo

New Comment - Rebecca Fitzgerald Lab & Peter Sasieni - Lessons learned from the BOSS trial: new directions in Barrett's oesophagus thelancet.com/journals/langa… #GITwitter #OncTwitter

What does the BOSS trial mean for the future of BE surveillance? We share key lessons learned and outline new directions for improving patient outcomes. Dive into our latest commentary here: thelancet.com/journals/langa… Peter Sasieni #Oncology #GIresearch #Barretts #Surveillance

'We need to move faster in trialling cancer screening tests,' says Professor of Cancer Epidemiology Queen Mary University of London Peter Sasieni as he presents on the NHS-Galleri trial of GRAIL’s multi-cancer early detection test in population screening at #ICSN2025

Totally psyched for the start of what I’m calling Cancer Prevention Research Celebration Week! Kicking off with CRUKCOLcentre’s “Learn the Basics: Primer on Cancer Prevention” — diving into the research continuum with world-leading experts. Let’s go! #PrevConf25

Evaluation of a novel capsule sponge triage pathway for patients routinely referred with reflux symptoms: safety, outcomes and impact on endoscopy from a large volume single site cohort over 4 years | Frontline Gastroenterologyc fg.bmj.com/content/early/…

Biomarker risk stratification with capsule sponge in the surveillance ... sciencedirect.com/science/articl…

NHS England adding at-home HPV testing to the cervical screening programme - Cancer Research UK - Cancer News news.cancerresearchuk.org/2025/06/24/at-…

At-home HPV testing is gaining momentum and may well prove to be a true game-changer in cervical cancer diagnosis and control. This innovative approach has the potential to significantly increase screening uptake, especially among those who face barriers to traditional

Just published in The Lancet! We show that the capsule sponge improves Barrett's surveillance, helping prioritize high-risk patients for endoscopy & offering a more efficient, patient-friendly approach for low-risk individuals. thelancet.com/journals/lance… #GITwitter #Earlydetection

1/8 🎉Thrilled to share our landmark study now published in The Lancet on a capsule sponge surveillance strategy for Barrett's oesophagus thelancet.com/journals/lance… presented at the BSG, Glasgow Cambridge University Early Cancer Institute, University of Cambridge Addenbrooke's Cancer Research UK Rebecca Fitzgerald Lab

Congratulations Anbu Paramasivam and team on a wonderfully organised and incredibly interesting #PrevConf25. Looking forward to next year's conference in Atlanta !

Rebecca Fitzgerald Lab talks to Chris Smith about a condition called Barrett's Oesophagus and a simple capsule sponge test which can replace expensive and invasive endoscopies. In fact, a recent paper in the Lancet proves the sponge actually improves surveillance. Listen in from 09:50.

Great Lecture and insights on ovarian cancer prevention by Profs Leigh Pearce and Gillian Hanley at WIPH on Monday 14/7 Women's Precision Prevention Wolfson Institute of Population Health Queen Mary University of London Barts Cancer Institute (Queen Mary) BGCS University of British Columbia Barts Health

Registration for #ECISymposium2025 is now open and we are delighted to reveal our speakers: Peter Sasieni, Clare Turnbull- Prof/NHS Dr, Sarah Blagden and Gonia Gozdecka Cambridge Stem Cell Institute. Abstract submissions are invited for lightning talks and posters by 07/09. 👉eci-symposium2025.eventbrite.co.uk